<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>研发客 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2021-01-04T07:32:49+08:00</updated>
  <subtitle>《研发客》公众号由上海汐潮信息技术有限公司提供，行业资深中英文独立编辑记者创办。我们观察药物创新生态，报道临床研究与监管科学。</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>时序更替的2020，请记住中国生物医药！| 年度</title>
    <updated>2021-01-03T23:18:10+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-03:/s/PaeV1OdJ3GC9WgsgQ7iXcQ</id>
    <link href="https://mp.weixin.qq.com/s/PaeV1OdJ3GC9WgsgQ7iXcQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>德琪医药在韩国提交ATG-010（Selinexor）新药上市申请，治疗复发难治性多发性骨髓瘤及弥漫性大B细胞淋巴瘤 |新闻稿</title>
    <updated>2021-01-03T23:18:10+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-03:/s/nmZ28ljq9zUg7TueWQfURg</id>
    <link href="https://mp.weixin.qq.com/s/nmZ28ljq9zUg7TueWQfURg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>警惕静脉注射剂中的苯甲醇引发的不良反应 | 正见</title>
    <updated>2021-01-02T22:55:29+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-02:/s/kjP7io2knxXegNc8Rh4Thw</id>
    <link href="https://mp.weixin.qq.com/s/kjP7io2knxXegNc8Rh4Thw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>“超光速行动”——科学的胜利 |老梁说药</title>
    <updated>2021-01-01T20:53:53+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-01:/s/iGXn4JVPDUTttQ61aJLHNQ</id>
    <link href="https://mp.weixin.qq.com/s/iGXn4JVPDUTttQ61aJLHNQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>创世纪 | 年度</title>
    <updated>2020-12-31T19:11:51+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-31:/s/lkJCIJsXmwmdrOnBwoHucw</id>
    <link href="https://mp.weixin.qq.com/s/lkJCIJsXmwmdrOnBwoHucw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>药物警戒制度上升到战略层面 | DRR专题· 新理念</title>
    <updated>2020-12-30T18:21:48+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-30:/s/bCKLxueB_XUR5JTx6YqEFA</id>
    <link href="https://mp.weixin.qq.com/s/bCKLxueB_XUR5JTx6YqEFA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>优先审评审批和特别审批：聚焦临床价值 | DRR·注册程序</title>
    <updated>2020-12-29T21:18:11+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-29:/s/F2ptxxA6oS8otlxF3mnaow</id>
    <link href="https://mp.weixin.qq.com/s/F2ptxxA6oS8otlxF3mnaow" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>20201230 本周职位精选：谷孚招聘科技项目主管 | 招聘</title>
    <updated>2020-12-29T21:18:11+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-29:/s/-AUxdNYBeFCVa5OlEuDVnQ</id>
    <link href="https://mp.weixin.qq.com/s/-AUxdNYBeFCVa5OlEuDVnQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>临床研究阶段两大加速通道 | DRR·注册程序</title>
    <updated>2020-12-28T23:19:06+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-28:/s/mVPMO6BKqt-A9Tzu5mNcFA</id>
    <link href="https://mp.weixin.qq.com/s/mVPMO6BKqt-A9Tzu5mNcFA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>信达生物战略升级 | 江湖</title>
    <updated>2020-12-27T23:06:18+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-27:/s/xDijcpqggA3gURBmC41EPA</id>
    <link href="https://mp.weixin.qq.com/s/xDijcpqggA3gURBmC41EPA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>来凯医药一类新药LAE002/Afuresertib和LAE005临床试验获批 | 新闻稿</title>
    <updated>2020-12-27T23:06:18+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-27:/s/tCFlqfzTGrnCcOJZlmKsrQ</id>
    <link href="https://mp.weixin.qq.com/s/tCFlqfzTGrnCcOJZlmKsrQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>东阳光药理解的“创新”内涵 | DRR专题·转型</title>
    <updated>2020-12-26T22:39:19+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-26:/s/_R7-X8TUUMAicFSKtG651Q</id>
    <link href="https://mp.weixin.qq.com/s/_R7-X8TUUMAicFSKtG651Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>研发客独家资本市场调研报告+药品注册法规蓝皮书，这里有机会免费拿！</title>
    <updated>2020-12-25T22:51:48+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-25:/s/yjW-cSpZmOyLPM0Owa-iAA</id>
    <link href="https://mp.weixin.qq.com/s/yjW-cSpZmOyLPM0Owa-iAA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>